MA Rep. Tests Positive For Coronavirus After Receiving Second Vaccine Dose

WASHINGTON, DC - DECEMBER 02: U.S. Rep. Stephen Lynch (D-MA) speaks during a House Financial Services Committee oversight hearing to discuss the Treasury Department's and Federal Reserve's response to the coronavirus... WASHINGTON, DC - DECEMBER 02: U.S. Rep. Stephen Lynch (D-MA) speaks during a House Financial Services Committee oversight hearing to discuss the Treasury Department's and Federal Reserve's response to the coronavirus (COVID-19) pandemic on December 02, 2020 in Washington, DC. Federal Reserve Chairman Jerome Powell and Treasury Secretary Steven Mnuchin are scheduled to testify. MORE LESS

Rep. Stephen Lynch (D-MA) has tested positive for the coronavirus, after receiving both doses of the Pfizer-BioNTech vaccine, according to multiple reports.

The news of Lynch’s diagnosis is a reminder to those who have recently received vaccinations to remain especially vigilant in the two weeks following the administration of the second dose, and to closely follow vaccine guidelines.

A spokesperson for Lynch, Molly Rose Tarpey, said in a statement obtained by CBS News that the congressman had received the second dose of the Pfizer vaccine and subsequently received a negative COVID-19 test before attending President Biden’s inauguration ceremony on Jan. 20. 

“While Mr. Lynch remains asymptomatic and feels fine, he will self-quarantine and will vote by proxy in Congress during the coming week,” she said.

Tarpey told CBS News that the Massachusetts lawmaker had tested positive for the virus on Friday afternoon after a staff member in his Boston office tested positive earlier in the week. 

Tarpey added that Lynch “has followed CDC guidelines and continues to do so since he received the vaccine.”

While the exact timing of when Lynch received his first and second doses of the vaccine is not immediately clear, medical experts have indicated that instances of positive tests for coronavirus after receiving the first or even both doses of the vaccine are not unexpected as vaccines are rarely, if ever, completely effective right away after they are administered.

Per clinical data, Pfizer’s vaccine is about 52 percent effective at preventing illness after the first dose, compared to 95 percent effectiveness seven days after the second shot the Post points out. 

Health experts also noted it typically takes one week after the second dose of the Pfizer-BioNTech vaccine to reach efficacy of 95 percent. It usually takes two weeks after the second dose of the Moderna vaccine to reach 94 percent efficacy, experts have said.

Trahan received her first shot of one of the vaccines last week, her spokesperson Francis Grubar told the Washington Post.

The news of Lynch’s positive diagnosis comes after another Democrat from Massachusetts, Rep. Lori Trahan, announced in a tweet on Thursday that she had tested positive for the virus and was asymptomatic. 

“I encourage everyone to continue taking this virus seriously and to follow the science and data-driven guidance to wear a mask, maintain a safe social distance from others, avoid large gatherings and stay home whenever possible,” Trahan said.

Dear Reader,

When we asked recently what makes TPM different from other outlets, readers cited factors like honesty, curiosity, transparency, and our vibrant community. They also pointed to our ability to report on important stories and trends long before they are picked up by mainstream outlets; our ability to contextualize information within the arc of history; and our focus on the real-world consequences of the news.

Our unique approach to reporting and presenting the news, however, wouldn’t be possible without our readers’ support. That’s not just marketing speak, it’s true: our work would literally not be possible without readers deciding to become members. Not only does member support account for more than 80% of TPM’s revenue, our members have helped us build an engaged and informed community. Many of our best stories were born from reader tips and valuable member feedback.

We do what other news outlets can’t or won’t do because our members’ support gives us real independence.

If you enjoy reading TPM and value what we do, become a member today.

Latest News
Masthead Masthead
Founder & Editor-in-Chief:
Executive Editor:
Managing Editor:
Associate Editor:
Investigations Desk:
Editor at Large:
General Counsel:
Head of Product:
Director of Technology:
Associate Publisher:
Front End Developer:
Senior Designer: